BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30498933)

  • 1. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.
    Hughes RL
    Forensic Sci Med Pathol; 2019 Mar; 15(1):110-113. PubMed ID: 30498933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of fatal overdose involving both hydromorphone and kratom.
    Shi T; Shea JL
    J Forensic Sci; 2024 Jan; 69(1):355-358. PubMed ID: 37753815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations.
    Tanna RS; Tian DD; Cech NB; Oberlies NH; Rettie AE; Thummel KE; Paine MF
    J Pharmacol Exp Ther; 2021 Jan; 376(1):64-73. PubMed ID: 33093187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
    Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
    Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatality of 33-Year-Old Man Involving Kratom Toxicity.
    Matson M; Schenk N
    J Forensic Sci; 2019 Nov; 64(6):1933-1935. PubMed ID: 31121058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review.
    Ya K; Tangamornsuksan W; Scholfield CN; Methaneethorn J; Lohitnavy M
    Asian J Psychiatr; 2019 Jun; 43():73-82. PubMed ID: 31100603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kratom-Associated Fatalities in Northern Nevada-What Mitragynine Level Is Fatal?
    Schmitt J; Bingham K; Knight LD
    Am J Forensic Med Pathol; 2021 Dec; 42(4):341-349. PubMed ID: 34091497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitragynine 'Kratom' related fatality: a case report with postmortem concentrations.
    McIntyre IM; Trochta A; Stolberg S; Campman SC
    J Anal Toxicol; 2015 Mar; 39(2):152-5. PubMed ID: 25516573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An accidental poisoning with mitragynine.
    Karinen R; Fosen JT; Rogde S; Vindenes V
    Forensic Sci Int; 2014 Dec; 245():e29-32. PubMed ID: 25453780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential for Kratom as an Antidepressant and Antipsychotic.
    Johnson LE; Balyan L; Magdalany A; Saeed F; Salinas R; Wallace S; Veltri CA; Swogger MT; Walsh Z; Grundmann O
    Yale J Biol Med; 2020 Jun; 93(2):283-289. PubMed ID: 32607089
    [No Abstract]   [Full Text] [Related]  

  • 11. A drug fatality involving Kratom.
    Neerman MF; Frost RE; Deking J
    J Forensic Sci; 2013 Jan; 58 Suppl 1():S278-9. PubMed ID: 23082895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of deaths associated with kratom use.
    Corkery JM; Streete P; Claridge H; Goodair C; Papanti D; Orsolini L; Schifano F; Sikka K; Körber S; Hendricks A
    J Psychopharmacol; 2019 Sep; 33(9):1102-1123. PubMed ID: 31429622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateral Flow Assessment and Unanticipated Toxicity of Kratom.
    Smith LC; Lin L; Hwang CS; Zhou B; Kubitz DM; Wang H; Janda KD
    Chem Res Toxicol; 2019 Jan; 32(1):113-121. PubMed ID: 30380840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitragynine concentrations in two fatalities.
    Domingo O; Roider G; Stöver A; Graw M; Musshoff F; Sachs H; Bicker W
    Forensic Sci Int; 2017 Feb; 271():e1-e7. PubMed ID: 28089300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Mitragynine Content, Levels of Toxic Metals and the Presence of Microbes in Kratom Products Purchased in the Western Suburbs of Chicago.
    Prozialeck WC; Edwards JR; Lamar PC; Plotkin BJ; Sigar IM; Grundmann O; Veltri CA
    Int J Environ Res Public Health; 2020 Jul; 17(15):. PubMed ID: 32751712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse.
    Kruegel AC; Grundmann O
    Neuropharmacology; 2018 May; 134(Pt A):108-120. PubMed ID: 28830758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug testing for mitragynine and kratom: Analytical challenges and medico-legal considerations.
    Helander A; Rylski A
    Drug Test Anal; 2023 Feb; 15(2):213-219. PubMed ID: 36258649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of
    Kamble SH; Sharma A; King TI; León F; McCurdy CR; Avery BA
    Xenobiotica; 2019 Nov; 49(11):1279-1288. PubMed ID: 30547698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Trouble With Kratom: Analytical and Interpretative Issues Involving Mitragynine.
    Papsun DM; Chan-Hosokawa A; Friederich L; Brower J; Graf K; Logan B
    J Anal Toxicol; 2019 Sep; 43(8):615-629. PubMed ID: 31424079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suspected Driving Under the Influence Case Involving Mitragynine.
    Wright TH
    J Anal Toxicol; 2018 Sep; 42(7):e65-e68. PubMed ID: 29718282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.